Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release  by Gourdji, D. et al.
Volume 104, number 1 FEBS LETTERS August 1979 
VASOACTIVE INTESTINAL PEPTIDE (VIP) STIMULATES PROLACTIN (PRL) RELEASE 
AND CAMP PRODUCTION IN A RAT PITUITARY CELL LINE (GH3/B6). 
ADDITIVE EFFECTS OF VIP AND TRH ON PRL RELEASE 
D. GOURDJI*, D. BATAILLE**,N. VAUCLIN**, D. GROUSELLE*, G. ROSSELIN** and A. TIXIER-VIDAL* 
*Groupe de Neuroendocrinologie Cellulaire, Loboratoire de Physiologie Cellulaire, Coll8ge’de France, 1 I Place Marcelin Berthelot, 
75231 Paris Cedex 05, France, and **IN.!iERM, U. 55, fIGpita St Antoine, 75645 Paris Cedex 12, France 
Received 7 June 1979 
1. Introduction 
The recent localization of VIP [l] (a peptide 
initially discovered inthe gastrointestinal tract) within 
the hypothalamus, the hypothalamo-hypophyseal 
portal blood and the adenohypophysis [2-61, 
strongly suggested its possible regulatory role on the 
pituitary gland. Kato et al. [7] and Vijayan et al. [8] 
have shown that VIP was actually able to stimulate 
the release of several adeno-hypophyseal hormones 
including prolactin (PRL) in vivo, but not in vitro. 
They concluded, therefore, that VIP was acting on 
the secretion of pituitary hormones by means of 
indirect mechanisms [7,8]. Ruberg et al. nevertheless, 
demonstrated a direct stimulating effect of VIP on 
PRL release by incubated rat hem&pituitaries [9]. 
We have investigated the responsiveness to VIP of 
a rat prolactin-secreting celI line, the GH3/B6. The 
hormonal secretion of these cells, or of related strains, 
has already been shown to be sensitive to various 
physiological modulators of PRL secretion in vivo, 
including thyroliberin (TRH) [lo] (for recent 
reviews ee refs. [ 11,121). Such an homogeneous 
population of target cells provides, therefore, a suit- 
able model for investigating a hypothetical effect of 
VIP on prolactin cells at the cellular and subcellular 
levels. Here, we show that the GH3/B6 cells are 
highly responsive to VIP which stimulates in a con- 
comitant manner both their PRL release and 3’,5’- 
cyclic adenosine monophosphate (CAMP) produc- 
tion. These effects of VIP were compared to those 
of TRH, a well-established hypothalamic PRLstim- 
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ulating factor [lo-l 21. The effect of VIP and TRH 
were found to be additive on PRL release, but not on 
CAMP production. 
2. Experimental 
2 .l . Cells and experimental schedules 
The GH3/B6 strain, a subclone of the GH3 rat 
pituitary tumor cell line [ 131, were routinely grown 
as monolayer in Ham’s F 10 medium enriched with 
heat-inactivated horse serum (15%) fetal calf serum 
(2.5%) and antibiotics as previously described [14]. 
In these conditions, they continuously secrete PRL 
and growth hormone as does the parent cell line [ 151. 
The cells used for the present work had been sub- 
cultured 12-17 times. For the experiments, 150 000 
cells/2 ml of medium/35 cm diameter-culture dishes 
were seeded and grown for 6 days at 37°C. Prior to 
the incubation, the medium was discarded, the cells 
rinsed with warm Ham’s F 10 solution and 900 ~1 
of complete culture medium (cf. above), containing 
or not 0.2 mM iso-butyl-methyl-xanthine (IBuMeXan), 
was added. Incubations were performed at 25’C f 1°C. 
After 5 mm, 100 (~1 of medium containing or not 
VIP, or TRH, or VIP plus TRH were introduced 
under gentle stirring. The medium of each dish was 
collected after a 15-min incubation and one ml of 
methanol immediately added to the cells. The 
medium was aliquoted for PRL assay and the rest 
(700 ~1) was gathered with the cells scraped in a total 
amount of 4 ml methanol. Parallel dishes were saved 
for cell number and protein assay determinations [ 161. 
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2.2. Prolactin assay 
PRL was radioimmunoassayed using the kit kindly 
provided by the NIAMDD, Rat Prolactin Distribution 
Program and polyethylene glycol as the precipitat~g 
agent. Samples were run in duplicate and estimated in 
terms of RP-1 equivalents. 
2.3. CAMP assay 
One ml of the supernatant of the methanol extract 
was evaporated, then succinylated in order to increase 
the sensitivity of the assay [173 and submitted to 
radioimmunoassay [ 181 using reagents and technical 
procedures developed in our laboratory [191. Each 
sample was run in one assay at two or three different 
dilutions. 
2.4. Reagents 
Highly purified natural porcine VIP was a generous 
gift from Pt. V. Mutt (Karolinska Institute, Stockholm, 
Sweden). Synthetic TRH was purchased from Cal- 
biochem (USA). Culture media, sera and reagents 
were purchased from Eurobio (Paris, France) and 
culture dishes from Coming or Falcon (USA). All 
other chemicals were of analytical grade from Merck 
(Darmstadt, GFR) or Prolabo (Paris, France). 
3. Results 
Figure 1 (upper pannel) shows that VIP was able 
to increase the release of PRL within 15 min of 
~cubation at 25”C, in a dose-dependent manner. The 
apparent h~f-rn~~urn stimulation occurred for 
ca. 2.8 X lo-“’ M. The maximal effect (3 times the 
basal evel) was reached for 1 O-* M VIP, while higher 
concentrations led to a lower stimulating effect. Con- 
comitantly, an augmentation of cell plus medium- 
CAMP was elicited by VIP. Although the CAMP 
increase at IO’” and 10 -lo M VIP was very limited, 
higher doses of VIP induced a highly significant 
enhancement of the CAMP production by the GH3/B6 
cells. It reached 170% of the basal CAMP level for 
10” M, corresponding to the optimal PRL response, 
and 230% of the basal production at lo-’ M, when 
the induced PRL release appeared sub-maximal. 
Figure 1 (lower pannel) illustrates the dose-depen- 
dent effect of TRH observed in parallel experiments. 
Although TRH appeared less potent than VIP, the 
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F&l. Dose-dependent effects of VIP (upper panel) and TRH 
(lower panel) on PRL release (solid lines) and CAMP production 
(interrupted lines). Experimental conditions are described in 
section 2. Each point represents the mean i S.E.M. of 
7 determinations from two experiments for PRL, and of 
4 determinations from one experiment for CAMP. Each dish 
contained ca. 1.2 x lo6 cells (350 gg protein) which produced 
under basalconditions9.7 f 0.85 ngofPRLand6.25 f 0.61 pmol 
of CAMP within 15 min. 
optimal increase of PRL release was of the same 
order of magnitude with either peptide. In contrast, 
TRH stimulated very poorly the CAMP production: 
the CAMP increment did not exceed 20% above con- 
trol and did not evoluate in a dose-dependent manner. 
In addition, increasing the TRH concentration from 
10” to IO-’ M induced a further enhancement in the 
PRL release contrasting with the disappearance of the 
minute increase of CAMP production. 
When cells were simultaneously exposed to VIP 
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Table 1 
Combined effects of VIP (10-s M) and TRH (10-s M) on PRL release and 
CAMP production 
Basal VIP VIP + TRH THR 
August 1979 
PRL 9.5 28.0 47.6 24.4 
&dish f 0.5 + 2.8 f 3.4 f 1.85 
% stimulation - + 194% + 400% + 154% 
CAMP 5.5 9.8 9.8 6.4 
pmole/dish f 0.80 f 0.28 it 0.55 * 0.40 
% stimulation - + 78% + 78% + 17% 
Each point is the mean f S.E.M. of 6 determinations from two experiments each 
performed in triplicate 
(lOa M) and TRH (10” M), an additive ffect was 
observed on the PRL release (table 1). In contrast, 
no additive ffect was observed concerning the CAMP 
production (table 1). 
4. Discussion 
Several lines of conclusions can be drawn from 
the present data. 
(1) VIP is actually a direct and powerful PRL 
releasing factor in GH3/B6 rat pituitary cells, in a 
range of doses which includes the VIP concentrations 
recently measured in the rat hypothalamo-hypophy- 
seal portal blood, i.e., 3 X lo-” M [5]. This cell line 
appears highly sensitive and responsive to VIP in 
terms of PRL release as compared to incubated rat 
hemi-pituitaries [9]. In addition, in the present 
experimental conditions, the VIP potency was higher 
than that of TRH. 
(2) VIP is an efficient stimulating peptide for 
CAMP production by prolactin-secreting cells. More- 
over, as shown in table 2, the addition of 0.2 mM 
IBuMeXan to the incubation medium led to a higher 
augmentation of the VIP-induced CAMP production, 
raised the basal PRL release, but partially masked the 
VIP-dependent hormonal release. It is noteworthy 
that, in all VIP-sensitive target issues tested, an 
augmentation of CAMP production and/or adenylate 
cyclase stimulation was observed: liver and fat cell 
membranes [ 20,2 11, human colonic carcinoma cells 
[ 221, rat enterocytes [23], isolated guinea-pig pan- 
creatic cells [24], subcellular particles from rat brain 
[25] and from a human prolactin-secreting pituitary 
Table 2 
Influence of IBuMeXan (0.2 mM) on VIP (10 nM)-induced CAMP production and 
PRL release by GH3/B6 cells 
With IBuMeXan 
CAMP 
pmoles/dish 
PRL 
ng/dish 
Without IBuMeXan 
CAMP PRL 
pmoles/dish ng/dish 
Basal 15.9 69.1 10.2 47.2 
f 1.08 f 2.19 f 0.47 f 2.71 
VIP 42.5 102.0 20.0 95.8 
f 1.41 f 3.81 f 3.76 + 3.00 
% of Basal 267% 147% 196% 200% 
Each point is the mean of triplicate i: S.E.M. 
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adenoma [26]. Our results thus suggest that the final 
biological response induced by VIP (i.e., PRL release) 
is under the control of a ~A~-dependent process. 
The observed shift of responsiveness between the 
increase of CAMP production and PRL release (fig.1) 
is not incompatible with such an hypothesis [27,28]. 
Nevertheless, further experiments must be performed 
to validate this interpretation. As far as the effect of 
TRH on PRL release is concerned, the direct involve- 
ment of CAMP is stilI controversial in spite of 
numerous experimental pproaches [ 29-3 1 ]. In our 
experiments, the CAMP production appeared barely 
dependent on TRH, and no additive ffect on CAMP 
production was observed when VIP and TRH were 
applied ~uit~eou~y; that contrasts with the additive 
effect observed on PRLrelease (table 1). These results 
strongly suggest the hypothesis that these two 
neuropeptides which finally generate the same 
hormonal response, trigger on the same target cell 
different subcellular mechanisms. 
The present work is the first demonstration that 
VIP stimulates directly the PRL release from PRL- 
secreting cell line. Together with other findings [2-91 
it supports the hypothesis that VIP is of physiological 
importance in the control of PRL secretion. 
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